Human-derived Enterococcus strain MNC-168
Term · Oncology and biomedicine · MLC-T-ONC-014254
An enteric-coated capsule formulation composed of a live Enterococcus strain derived from the human gut microbiome, with potential immunostimulating and antineoplastic activities. Upon administration of the human-derived Enterococcus strain MNC-168, the bacteria may activate the immune system through various mechanisms, including, but not limited to, the recruitment of tumor-infiltrating lymphocytes (TILs) and cytotoxic CD4+ and CD8+ T cells in the tumor microenvironment (TME). This may enhance anti-tumor immune responses and may eradicate tumor cells.
| Identifier | MLC-T-ONC-014254 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | live bacterium MNC-168; human-derived live biotherapeutic product MNC-168 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014254",
"term": "Human-derived Enterococcus strain MNC-168",
"field": "Oncology and biomedicine",
"definition": "An enteric-coated capsule formulation composed of a live Enterococcus strain derived from the human gut microbiome, with potential immunostimulating and antineoplastic activities. Upon administration of the human-derived Enterococcus strain MNC-168, the bacteria may activate the immune system through various mechanisms, including, but not limited to, the recruitment of tumor-infiltrating lymphocytes (TILs) and cytotoxic CD4+ and CD8+ T cells in the tumor microenvironment (TME). This may enhance anti-tumor immune responses and may eradicate tumor cells.",
"synonyms": [
"live bacterium MNC-168",
"human-derived live biotherapeutic product MNC-168"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/human-derived-enterococcus-strain-mnc-168/"
}
Record 8,767 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.